Brief: Vbl Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
15/05/2023 21:30
Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* VASCULAR BIOGENICS LTD - QTRLY LOSS PER SHARE $0.03
Source text for Eikon: ID:nGNX33ZycD
Further company coverage: VBLT.O
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives